Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Gynecol Oncol. 2014 Apr 12;133(3):546–551. doi: 10.1016/j.ygyno.2014.04.002

Table 2. Overall Study Cohort Treatment Outcomes.

Variable N %

Primary Treatment
Surgery 148 97.4
Chemo/Rads1 4 2.6
Surgical Approach
MIS2 78 52.7
Laparotomy 62 41.9
Groin 8 5.4
Postoperative Course (30 Day)
Intra op complication3 14 9.5
Postop morbidity4 37 25.0
ICU Admission 6 4.0
Death 1 0.7
Discharge Location
Home 143 96.6
SNF3 4 2.7
Acute Rehab6 1 0.7
Unplanned Post-op Resource Use (30 Day)
Clinic Visit 9 6.1
ER Visit 18 12.1
Readmission 17 11.5
Adjuvant Treatment
Recommended 94 63.5
Not Recommended 54 36.5
Treatment Started 74 78.8%
No Treatment started 20 21.2%
1

Chemotherapy and/or Radiation

2

Minimally invasive surgery including laparoscopic, robotic, or hysteroscopic approach

3

Includes bladder, ureteral, vascular, nerve, and GI injury

4

Includes VTE/PE, Abscesses, Cardiac event, renal insufficiency, pulmonary events, organ injury, wound infection, wound opening, ileus, blood transfusion, urinary tract infection

5

Skilled nursing facility or Sub-acute rehabilitation facility

6

Acute inpatient rehabilitation facility